(Q36568992)

15 August 2017

Pro-inflammatory chemokine C-C motif ligand 16 (CCL-16) dysregulation in irritable bowel syndrome (IBS): a pilot study (English)

1 reference

inflammatory bowel diseases

15 August 2017

0 references

irritable bowel syndrome

1 reference

A Y Del Valle-Pinero

1

1 reference

15 August 2017

A C Martino

2

1 reference

15 August 2017

T J Taylor

3

1 reference

15 August 2017

B L Majors

4

1 reference

15 August 2017

N S Patel

5

1 reference

15 August 2017

M M Heitkemper

6

1 reference

15 August 2017

W A Henderson

7

1 reference

15 August 2017

23 September 2011

1 reference

Neurogastroenterology and Motility

15 August 2017

1 reference

15 August 2017

23

1 reference

15 August 2017

12

1 reference

15 August 2017

1092-1097

1 reference

The association of mast cells and serotonin in children with chronic abdominal pain of unknown etiology.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Is irritable bowel syndrome an inflammatory disorder?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Alterations in mucosal immunity identified in the colon of patients with irritable bowel syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Intestinal permeability and irritable bowel syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

The role of gender and biological sex in irritable bowel syndrome

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Inflammation as a basis for functional GI disorders.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

The expression of LEC/CCL16, a powerful inflammatory chemokine, is upregulated in ulcerative colitis.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

A role for inflammation in irritable bowel syndrome?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Functional bowel disorders and functional abdominal pain

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Isolation and characterization of LMC, a novel lymphocyte and monocyte chemoattractant human CC chemokine, with myelosuppressive activity

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Testing significance relative to a fold-change threshold is a TREAT.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Isolation of cDNA encoding a novel human CC chemokine NCC-4/LEC.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

The functional gastrointestinal disorders and the Rome III process

28 June 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01792.X

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01792.X

Intestinal permeability in patients with irritable bowel syndrome after a waterborne outbreak of acute gastroenteritis in Walkerton, Ontario

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01792.X

CCL16/LEC powerfully triggers effector and antigen-presenting functions of macrophages and enhances T cell cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2982.2011.01792.X

Patient knowledge and educational needs in irritable bowel syndrome

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3557463

Mucosal barrier defects in irritable bowel syndrome. Who left the door open?

21 September 2018

1 reference

12 December 2020

Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes

1 reference

12 December 2020

1 reference

12 December 2020

Irritable bowel syndrome

1 reference

12 December 2020

Irritable bowel syndrome

1 reference

12 December 2020

10.1111/J.1365-2982.2011.01792.X

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

21951809

1 reference